Christoph Kopp

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

K. Zaman, A. Stathis, O. Michielin, 2022, Cancers.

Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)

B. Thürlimann, S. Schär, B. Kasenda, 2023, BMJ Open.